ベーチェット病の世界市場レポート 2025年

ベーチェット病市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.2％で、17億1,000万米ドルに成長します。予測期間中に予想される成長は、自己免疫疾患や炎症性疾患に関する研究の増加、臨床試験や研究イニシアチブの増加、個別化治療アプローチの開発、新興地域におけるヘルスケアアクセスの改善、患者中心のケアモデルの重視の高まりが原動力になるとみられます。予測期間中に予測される主な動向としては、診断法の革新、精密医療の進展、遠隔医療やデジタルヘルスケアソリューションへのシフト、製薬企業と研究機関の協力関係の強化、新規併用療法の出現などが挙げられます。

希少疾患に対するヘルスケア投資の増加は、今後数年間におけるベーチェット病市場の成長を牽引すると予想されます。希少疾患とは、2,000人に1人未満が罹患する疾患と定義され、複雑な症状や限られた治療選択肢を特徴とすることが多いです。この投資急増の主な要因は、有効な治療法がない患者が多く、アンメット・メディカル・ニーズに対する認識が高まっていることです。その結果、政府や製薬会社はこの分野の研究開発、資金調達を優先しています。ベーチェット病は、集中的な研究努力によって希少疾患全体の治療や政策がいかに大きく前進するかを示すケーススタディとなっています。例えば、2024年4月、米国を拠点とする非営利団体Global Genesは、2024年第1四半期に、希少疾患の治療法を開発する会社が公開株式および債券による資金調達を通じて71億米ドルを調達したと報告しました。したがって、希少疾患に対するヘルスケア投資の増加がベーチェット病市場の成長に大きく寄与しています。

ベーチェット病市場の各社は、炎症と関連症状をより効果的に管理するために、自然防御調節薬（IDRs）のような免疫系調節に焦点を当てた新規治療法の開拓に力を入れています。IDRsは合成ペプチドであり、身体の自然な防御を増強することによって自然免疫反応を調節するように設計されています。ベーチェット病では、過剰な免疫活性と炎症を制御し、病気の症状を緩和し、再燃を抑える可能性があります。例えば、米国を拠点とするバイオ医薬品会社Soligenix, Inc.は、2024年11月、ベーチェット病患者の免疫反応を調節し、炎症を緩和することを目的としたIDRであるSGX945（ダスクエチド）を評価する第2相臨床試験（プロトコル番号DUS-AUBD-01）の患者登録を開始しました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ベーチェット病 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のベーチェット病市場：成長率分析
• 世界のベーチェット病市場の実績：規模と成長、2019～2024年
• 世界のベーチェット病市場の予測：規模と成長、2024～2029年、2034年
• 世界ベーチェット病総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のベーチェット病市場：治療の種類別、実績と予測、2019～2024年、2024～2029年、2034年
• コルチコステロイド
• 免疫抑制剤
• 生物学的製剤
• その他の治療法
• 世界のベーチェット病市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 注射
• 局所
• 世界のベーチェット病市場：病気の種類別、実績と予測、2019～2024年、2024～2029年、2034年
• 非眼性ベーチェット病
• 眼ベーチェット病
• 世界のベーチェット病市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界のベーチェット病市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 外来手術センター
• 世界のベーチェット病市場：コルチコステロイドの種類別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口コルチコステロイド
• 局所コルチコステロイド
• 静脈内コルチコステロイド
• 世界のベーチェット病市場：免疫抑制剤の種類別、実績と予測、2019～2024年、2024～2029年、2034年
• メトトレキサート
• アザチオプリン
• シクロホスファミド
• ミコフェノール酸モフェチル
• シクロスポリン
• 世界のベーチェット病市場：生物製剤の種類別、実績と予測、2019～2024年、2024～2029年、2034年
• 腫瘍壊死因子（TNF）阻害剤
• インターロイキン阻害剤
• 世界のベーチェット病市場：その他の治療法の種類別、実績と予測、2019～2024年、2024～2029年、2034年
• コルヒチン
• サリドマイド
• ヒドロキシクロロキン
• コルチコステロイド節約薬

第7章 地域別・国別分析

• 世界のベーチェット病市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のベーチェット病市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ベーチェット病市場：競合情勢
• ベーチェット病市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sandoz International GmbH
• Chugai Pharmaceutical Co. Ltd
• Sun Pharmaceutical Industries Limite
• Eisai Co. Ltd
• Pharmascience Inc
• Samsung Bioepis Co. Ltd.
• Maxivision Eye Hospitals Pvt. Ltd
• Ainos Inc.
• Soligenix Inc
• XOMA Corporation
• Creabilis S.A.
• Iltoo Pharma S.A.S.
• Ganzhou Hemay Pharmaceutical Co. Ltd.
• Sanguine Biosciences Inc.
• NYU Langone Health

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ベーチェット病市場2029：新たな機会を提供する国
• ベーチェット病市場2029：新たな機会を提供するセグメント
• ベーチェット病市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Behcet's disease is a rare, chronic inflammatory condition that affects multiple systems in the body, characterized by recurring inflammation in areas such as the eyes, mouth, skin, and genitals. It is considered a type of vasculitis, involving inflammation of both large and small blood vessels.

The primary treatment options for Behcet's disease include corticosteroids, immunosuppressants, biologics, and other therapies. Corticosteroids are anti-inflammatory medications commonly used to alleviate symptoms such as eye irritation, skin lesions, and mouth ulcers by controlling inflammation. These treatments can be administered in various forms, including oral, injectable, and topical routes, and are applicable to both ocular and non-ocular forms of the disease. The medications are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other outlets. They are used by healthcare providers in hospitals, clinics, ambulatory surgical centers, and other medical facilities.

The behcets disease market research report is one of a series of new reports from The Business Research Company that provides behcets disease market statistics, including behcets disease industry global market size, regional shares, competitors with a behcets disease market share, behcets disease market segments, market trends, and opportunities, and any further data you may need to thrive in the behcets disease industry. This behcets disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The behcets disease market size has grown strongly in recent years. It will grow from $1.15 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to increased awareness of rare diseases, the availability of biologic treatments, the expansion of healthcare infrastructure, the rising prevalence of autoimmune conditions, and greater adoption of biologic therapies.

The behcets disease market size is expected to see strong growth in the next few years. It will grow to $1.71 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth anticipated in the forecast period is expected to be driven by increased research into autoimmune and inflammatory diseases, a rising number of clinical trials and research initiatives, the development of personalized treatment approaches, improved healthcare access in emerging regions, and a growing emphasis on patient-centered care models. Key trends projected for the forecast period include innovations in diagnostic methods, progress in precision medicine, a shift toward telemedicine and digital healthcare solutions, increased collaboration between pharmaceutical companies and research organizations, and the emergence of novel combination therapies.

Increasing healthcare investment in rare diseases is expected to drive the growth of the Behcet's disease market in the coming years. Rare diseases are defined as conditions affecting fewer than 1 in 2,000 people and are often marked by complex symptoms and limited treatment options. This investment surge is primarily fueled by the growing awareness of unmet medical needs, with many patients lacking effective therapies. As a result, governments and pharmaceutical companies are prioritizing research, development, and funding in this space. Behcet's disease serves as a case study demonstrating how concentrated research efforts can lead to broader advances in treatment and policy across the rare disease landscape. For example, in April 2024, Global Genes, a U.S.-based nonprofit organization, reported that in the first quarter of 2024, companies developing treatments for rare diseases raised $7.1 billion through public equity and debt financings-an increase of 307% from the $1.8 billion raised during the same period in 2023. Therefore, increased healthcare investment in rare diseases is significantly contributing to the growth of the Behcet's disease market.

Companies in the Behcet's disease market are emphasizing the development of novel treatments focused on immune system modulation, such as innate defense regulators (IDRs), to manage inflammation and associated symptoms more effectively. IDRs are synthetic peptides designed to regulate the innate immune response by enhancing the body's natural defenses. In Behcet's disease, they help control excessive immune activity and inflammation, potentially easing disease symptoms and reducing flare-ups. For instance, in November 2024, Soligenix, Inc., a U.S.-based biopharmaceutical firm, began enrolling patients for a Phase 2 clinical trial (protocol number DUS-AUBD-01) to evaluate SGX945 (dusquetide), an IDR intended to modulate the immune response and alleviate inflammation in patients with Behcet's disease.

In May 2023, Soligenix, Inc., a U.S.-based company focused on treatments for rare diseases with unmet medical needs, entered into a partnership with Silk Road Therapeutics to target Behcet's disease. Through this exclusive option agreement, Soligenix obtained rights to develop topical pentoxifylline, aiming to provide new treatment options for Behcet's disease, a chronic inflammatory condition marked by recurrent mucocutaneous ulcers. Silk Road Therapeutics is a U.S.-based biopharmaceutical company specializing in innovative therapies for rare diseases, particularly Behcet's disease.

Major players in the behcets disease market are AbbVie Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Chugai Pharmaceutical Co. Ltd, Sun Pharmaceutical Industries Limite, Eisai Co. Ltd, Pharmascience Inc, Samsung Bioepis Co. Ltd., Maxivision Eye Hospitals Pvt. Ltd, Ainos Inc., Soligenix Inc, XOMA Corporation, Creabilis S.A., Iltoo Pharma S.A.S., Ganzhou Hemay Pharmaceutical Co. Ltd., Sanguine Biosciences Inc., NYU Langone Health

North America was the largest region in the behcets disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in behcets disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the behcets disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The behcets disease market consists of revenues earned by entities by providing services such as diagnostic testing, immunosuppressive and biologic treatment administration, patient care and support programs, surgical interventions for complications, and clinical research and development activities. The market value includes the value of related goods sold by the service provider or included within the service offering. The behcets disease market also includes sales of immunosuppressive drugs, biologic therapies, corticosteroids, colchicine, topical agents, and ophthalmic solutions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Behcets disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on behcets disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for behcets disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The behcets disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Corticosteroids; Immunosuppressants; Biologics; Other Treatments
• 2) By Route Of Administration: Oral; Injectable; Topical
• 3) By Type of Disease: Non-Ocular Behcet's Disease; Ocular Behcet's Disease
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 5) By End User: Hospitals; Clinics; Ambulatory Surgical Centers
• Subsegments:
• 1) By Corticosteroids: Oral Corticosteroids; Topical Corticosteroids; Intravenous Corticosteroids
• 2) By Immunosuppressants: Methotrexate; Azathioprine; Cyclophosphamide; Mycophenolate Mofetil; Cyclosporine
• 3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin Inhibitors
• 4) By Other Treatments: Colchicine; Thalidomide; Hydroxychloroquine; Corticosteroid-Sparing Agents
• Companies Mentioned: AbbVie Inc.; AstraZeneca PLC; GlaxoSmithKline PLC; Amgen Inc.; Teva Pharmaceutical Industries Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Behcets Disease Market Characteristics

3. Behcets Disease Market Trends And Strategies

4. Behcets Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Behcets Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Behcets Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Behcets Disease Market Growth Rate Analysis
• 5.4. Global Behcets Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Behcets Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Behcets Disease Total Addressable Market (TAM)

6. Behcets Disease Market Segmentation

• 6.1. Global Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Immunosuppressants
• Biologics
• Other Treatments
• 6.2. Global Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Topical
• 6.3. Global Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Ocular Behcet's Disease
• Ocular Behcet's Disease
• 6.4. Global Behcets Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.5. Global Behcets Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• 6.6. Global Behcets Disease Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Corticosteroids
• Topical Corticosteroids
• Intravenous Corticosteroids
• 6.7. Global Behcets Disease Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Methotrexate
• Azathioprine
• Cyclophosphamide
• Mycophenolate Mofetil
• Cyclosporine
• 6.8. Global Behcets Disease Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tumor Necrosis Factor (TNF) Inhibitors
• Interleukin Inhibitors
• 6.9. Global Behcets Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Colchicine
• Thalidomide
• Hydroxychloroquine
• Corticosteroid-Sparing Agents

7. Behcets Disease Market Regional And Country Analysis

• 7.1. Global Behcets Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Behcets Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Behcets Disease Market

• 8.1. Asia-Pacific Behcets Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Behcets Disease Market

• 9.1. China Behcets Disease Market Overview
• 9.2. China Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Behcets Disease Market

• 10.1. India Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Behcets Disease Market

• 11.1. Japan Behcets Disease Market Overview
• 11.2. Japan Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Behcets Disease Market

• 12.1. Australia Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Behcets Disease Market

• 13.1. Indonesia Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Behcets Disease Market

• 14.1. South Korea Behcets Disease Market Overview
• 14.2. South Korea Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Behcets Disease Market

• 15.1. Western Europe Behcets Disease Market Overview
• 15.2. Western Europe Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Behcets Disease Market

• 16.1. UK Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Behcets Disease Market

• 17.1. Germany Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Behcets Disease Market

• 18.1. France Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Behcets Disease Market

• 19.1. Italy Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Behcets Disease Market

• 20.1. Spain Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Behcets Disease Market

• 21.1. Eastern Europe Behcets Disease Market Overview
• 21.2. Eastern Europe Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Behcets Disease Market

• 22.1. Russia Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Behcets Disease Market

• 23.1. North America Behcets Disease Market Overview
• 23.2. North America Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Behcets Disease Market

• 24.1. USA Behcets Disease Market Overview
• 24.2. USA Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Behcets Disease Market

• 25.1. Canada Behcets Disease Market Overview
• 25.2. Canada Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Behcets Disease Market

• 26.1. South America Behcets Disease Market Overview
• 26.2. South America Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Behcets Disease Market

• 27.1. Brazil Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Behcets Disease Market

• 28.1. Middle East Behcets Disease Market Overview
• 28.2. Middle East Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Behcets Disease Market

• 29.1. Africa Behcets Disease Market Overview
• 29.2. Africa Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Behcets Disease Market Competitive Landscape And Company Profiles

• 30.1. Behcets Disease Market Competitive Landscape
• 30.2. Behcets Disease Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Behcets Disease Market Other Major And Innovative Companies

• 31.1. Sandoz International GmbH
• 31.2. Chugai Pharmaceutical Co. Ltd
• 31.3. Sun Pharmaceutical Industries Limite
• 31.4. Eisai Co. Ltd
• 31.5. Pharmascience Inc
• 31.6. Samsung Bioepis Co. Ltd.
• 31.7. Maxivision Eye Hospitals Pvt. Ltd
• 31.8. Ainos Inc.
• 31.9. Soligenix Inc
• 31.10. XOMA Corporation
• 31.11. Creabilis S.A.
• 31.12. Iltoo Pharma S.A.S.
• 31.13. Ganzhou Hemay Pharmaceutical Co. Ltd.
• 31.14. Sanguine Biosciences Inc.
• 31.15. NYU Langone Health

32. Global Behcets Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Behcets Disease Market

34. Recent Developments In The Behcets Disease Market

35. Behcets Disease Market High Potential Countries, Segments and Strategies

• 35.1 Behcets Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Behcets Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Behcets Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer